Calithera Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Calithera Biosciences

09/11/2021 22:52

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of 15 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 23 cents per share.
* Revenue was $6.75 million​;  analysts expected zero. 
* Calithera Biosciences Inc's reported EPS for the quarter was a
loss of 15 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.5% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Calithera Biosciences Inc shares had fallen by 59.7% this
quarter and lost 82.1% so far this year.
* The company reported a quarterly loss of $11.17 million.
* Wall Street's median 12-month price target for Calithera
Biosciences Inc is $1.50 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 10:52 p.m.
 ​All figures in US dollars unless otherwise stated